Introduction to the genetics of primary renal tumors in children
✍ Scribed by Knudson, Alfred G.
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 595 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Wilms tumor can be explained only partially by the “two hit” model that was originally developed for retinoblastoma. Heterogeneity of two kinds, operates. The first is that four other primary tumors are regularly observed in children, and the second is that Wilms tumor itself appears to represent more than one genetic entity. All five of these primary renal tumors arise from primary or secondary mesenchyme, renal blastema, or renal epithelium. Mesoblastic nephroma, and possibly clear cell sarcoma, may have some genetic affinity with Wilms tumor, but rhabdoid tumor of the kidney and renal carcinoma do not. At least three different genes seem to be important in the origin of Wilms tumor. One, WT1, whose mutations may be associated with aniridia, may follow the “two hit” model in that there are cases in which both copies of the gene are defective or lost, as expected for a tumor suppressor gene. A second gene, which is associated with Beckwith‐Wiedemann Syndrome (BWS) and which has not been cloned, appears to be imprinted in females, and may have an oncogene function. It is evidently activated by gain of a paternal allele or by loss of the inactive, but possibly trans‐sensing, maternal allele. Activation of the insulin‐like growth factor II gene may be a final common pathway for mutation in both WT1 and BWS. A third gene is unlinked to either of the other two, but its location and function are unknown. It shares with WT1 specificity for Wilms tumor, which is not true of the BWS gene. © 1993 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The clonal loss of genetic information as revealed by the comparison of normal and tumor DNA restriction fragment length alleles has permitted the determination of the genomic positions of cancer‐recessive mutations. Here we have applied this approach to the analysis of 19 central nervo
Our objechves include: i) determirung correlations between Wilms' tumor-specific molecular genehc events and clinicopathologc features; (ii) identifyrig hrther DNA/chromosomal aberrations; and (iii) establishing a Wilms' tumor tissue bank. To this end, a Witms' tumor biology protocol has been develo